Patient Guide: A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 85 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04576455
Status: ACTIVE_NOT_RECRUITING
Condition: Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 85 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Marietta, Georgia
  • Cleveland, Ohio
  • Tigard, Oregon
  • • And 82 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily